Nov 29 2010
The technologies that constitute molecular diagnostics--like first-generation amplification, DNA probes, fluorescent in situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors, and molecular labels--are influencing the discovery of therapeutic molecules, the screening and diagnosis of patients, and the optimization of drug therapy.
In the past few years, this rapidly evolving field has seen several fascinating developments. This report describes the specific market segment of the in vitro diagnostics market known as molecular diagnostics and includes all of the generally accepted clinical analytical activities in use today. It examines the prevalent clinical-measurement devices, as well as their reagents and supplies as utilized in hospitals, clinics, large reference laboratories and doctor´s offices. Diagnostic tests marketed primarily as over-the-counter are generally not included in this report, although there is inevitably some overlap.
The main objectives of this analysis are:
- identifying viable technology drivers through a comprehensive look at platform technologies for molecular diagnostics, including probe-based nucleic acid assays, microarrays and sequencing;
- obtaining a complete understanding of the chief molecular diagnostics tests--i.e., predictive, screening, prognostic, monitoring, pharmacogenomic and theranostic--from their basic principles to their applications;
- discovering feasible market opportunities by identifying high-growth applications in different clinical diagnostic areas and by focusing on expanding markets, such as communicable diseases, cardiology and oncology; and
- focusing on global industry development through an in-depth analysis of the major world markets for molecular diagnostics, including growth forecasts.
CompaniesandMarkets.com provides a wide range of research reports, industry statistics and competitive intelligence on the markets of the industrial sector. Topics covered include pharmaceuticals, biopharma, medical devices, vaccines, drug pipeline analysis, life sciences, biotech, partnering agreements, alliances and many other pharmaceutical and healthcare markets.
Source: http://companiesandmarkets.com/